TrialCancer2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
Glenn J Hanna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papertrialcites it
TrialCancer2020
Glenn J Hanna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.